- Pfizer agreed to pay $2.3 billion in 2009
- Novartis agreed to pay $423 million in 2010
- Sanofi Aventis to pay more tan $95 million to settle fraud charge in 2009
- GlaxoSmithKline to pay $3 billion in 2011
- AstraZeneca to pay $520 million in 2010 to settle fraud case
- Roche convinces governments to stockpile Tamiflu
- Johnson & Johnson fined more than $1.1 billion in 2012
- Merck to pay $670 million over Medicaid fraud in 2007
- Eli Lilly to pay more tan $1.4 billion for illegal marketing in 2009
- Abbott to pay $1.5 billion for Medicaid fraud in 2012
miércoles, 11 de septiembre de 2013
BMJ: 10 Big Pharma corporate crime / "common, serious and repetitive"
Ver
Etiquetas:
Abbott,
Agrupaciones,
AZ,
Fuerza de Ventas,
Glaxo,
Investigación,
J_J,
Lilly,
Marketing,
Merck,
Novartis,
Pfizer,
Promocion,
Roche,
SanofiAventis
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario